Back to Search

KYLIE CORMIER, MD

MD

Pediatrics Physician

NPI: 1598706087Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

A88098(CA)42318(TN)

Research & Publications (20)

Anti-inflammatory treatment in AD mice protects against neuronal pathology.
PMID 19679126·Exp Neurol·2010
7-preclinical
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.
PMID 18618304·Amyotroph Lateral Scler·2009
7-preclinical
Preference for Na+-pi binding over Na+-dipole binding in Na+-arene interactions.
PMID 19413284·J Phys Chem A·2009
8-other
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
PMID 19476553·J Neurochem·2009
7-preclinical
Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.
PMID 18319327·Hum Mol Genet·2008
7-preclinical
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.
PMID 18206128·Biochim Biophys Acta·2008
7-preclinical
The British Sign Language (BSL) norms for age of acquisition, familiarity, and iconicity.
PMID 19001399·Behav Res Methods·2008
8-other
Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.
PMID 18799679·J Neurosci·2008
7-preclinical
Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus.
PMID 18559427·Infect Immun·2008
7-preclinical
No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome.
PMID 17448874·Int J Radiat Oncol Biol Phys·2007
7-preclinical
Hepatocellular carcinoma associated with liver-gender disruption in male mice.
PMID 18089782·Cancer Res·2007
7-preclinical
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.
PMID 18032664·J Neurosci·2007
4-observational
Nortriptyline delays disease onset in models of chronic neurodegeneration.
PMID 17686041·Eur J Neurosci·2007
7-preclinical
Modulation of nucleosome dynamics in Huntington's disease.
PMID 17403718·Hum Mol Genet·2007
7-preclinical
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
PMID 17142323·Proc Natl Acad Sci U S A·2006
7-preclinical
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
PMID 16647250·Biochim Biophys Acta·2006
7-preclinical
Thiol-reactive compounds prevent nonspecific antibody binding in immunohistochemistry.
PMID 16534499·Lab Invest·2006
7-preclinical
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
PMID 16364609·Biochim Biophys Acta·2006
7-preclinical
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
PMID 16127709·J Comp Neurol·2005
7-preclinical
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
PMID 15934930·J Neurochem·2005
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
7640 HIGHWAY 70 S, SUITE 202
NASHVILLE, TN 37221

Location

Practice Location

7640 HIGHWAY 70 S, NASHVILLE, TN
(615) 352-2990

Quick Facts

NPI
1598706087
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile